Lin BioScience’s LBS-007 gets US FDA Fast Track Designation to treat acute myeloid leukaemia and acute lymphocytic leukaemia: Taipei City, Taiwan Friday, November 29, 2024, 12:0 ...
Geron Corporation , a commercial-stage biopharmaceutical company, today announced that members of the management team are scheduled to participate in a fireside chat at the 7th Annual Evercore ISI ...
LBS-007 functions by blocking the kinase activity of CDC7, a key regulator of the cancer cell cycle. Inhibiting CDC7 stops the proliferation of tumor cells and results in cancer cell death. LBS-007 ...